Alternative Approaches to Treating Gastrointestinal Stromal Tumors
When it comes to gastrointestinal stromal tumors (GISTs), surgery is not always a viable option. In cases where the tumor is too large to be removed or has already metastasized, cancer treatment becomes the main course of action. GISTs can range from small, benign growths to aggressive soft-tissue cancers, and healthcare professionals take into account the specific genetic characteristics of the tumor when determining the most appropriate medication for treatment.
Factors Affecting the Prognosis of Gastrointestinal Stromal Tumors
The prognosis of gastrointestinal stromal tumors (GISTs) is determined by several factors, including tumor size, location, and rate of growth. GISTs that are smaller than 2 inches in size and exhibit slow growth are generally associated with a favorable prognosis, as they rarely metastasize. However, it is important to note that the location of the tumor also plays a role in determining the likelihood of spreading. GISTs located in the small intestine are more prone to metastasis compared to those found in the stomach.